There should be a structure too. Step one, consisting of identifying the primary cause. Once we got the etiology, we move to the second step, which is to treat the underlying condition. For example, if a metabolic disorder is detected, we have to correct it. If there is a structural lesion, we should treat it. Or if there is an immune-mediated disorder, we give the patient immunotherapy like intravenous immunoglobulin, plasma exchange, or methylprednisolone...
There should be a structure too. Step one, consisting of identifying the primary cause. Once we got the etiology, we move to the second step, which is to treat the underlying condition. For example, if a metabolic disorder is detected, we have to correct it. If there is a structural lesion, we should treat it. Or if there is an immune-mediated disorder, we give the patient immunotherapy like intravenous immunoglobulin, plasma exchange, or methylprednisolone. But in case that the movement disorder persisted even after correction of the primary disorder, we give the patients symptomatic treatment, levodopa or dopaminergic therapy for Parkinsonism, levetiracetam, clonazepam, benzodiazepine for myoclonus, antipsychotics, dopamine-depleting drugs or tetrabenazine for chorea, athetosis, ballism, and so on. There are not always neurologists on call at the emergency room. We should also train the doctors at the ER department to be able to recognize the ER movement disorder. In case that there are neurologists on call, they should be ready to ask for our specific support that helps the patient to solve the problem.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.